Literature DB >> 14575825

Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.

Claudio Fiorino1, Giuseppe Sanguineti, Cesare Cozzarini, Gianni Fellin, Franca Foppiano, Loris Menegotti, Anna Piazzolla, Vittorio Vavassori, Riccardo Valdagni.   

Abstract

PURPOSE: To investigate the relationship between rectal bleeding and dosimetric-clinical parameters in patients receiving three-dimensional conformal radiotherapy (3D-CRT) for localized prostate cancer.
METHODS: In a retrospective national study (AIROPROS01-01, AIRO: Associazione Italiana Radioterapia Oncologica), planning/clinical data for 245 consecutive patients with stage T1-4N0-x prostate carcinoma who underwent 3D-CRT to 70-78 Gy (ICRU point) were pooled from four Italian institutions. The correlation between late rectal bleeding and rectal dose-volume data (the percentage of rectum receiving more than 50, 55, 60, 65, 70, and 75 Gy [V(50-70)]) and other dosimetric and clinical parameters were investigated in univariate (log-rank) and multivariate (Cox regression model) analyses. Median follow-up was 2 years.
RESULTS: Twenty-three patients were scored as late bleeders according to a modified RTOG definition (Grade 2: 16; Grade 3: 7); the actuarial 2-year rate was 9.2%. Excepting V75, all median and third quartile V(50-70) values were found to be significantly correlated with late bleeding at univariate analysis. The smallest p value was seen for V(50) below/above the third quartile value (66%). The V70 (cut-off value: 30%) was found to be also predictive for late bleeding. In the high-dose subgroup (74-78 Gy), Grade 3 bleeding was highly correlated with this constraint. The predictive value of both V(50) and V(70) was confirmed by multivariate analyses.
CONCLUSIONS: The present article provides evidence for correlation between rectal DVH parameters and late rectal bleeding in patients treated with curative intent with 3D-CRT. To keep the rate of moderate/severe rectal bleeding below 5-10%, it seems advisable to limit V(50) to 60-65%, V(60) to 45-50%, and V70 to 25-30%.

Entities:  

Mesh:

Year:  2003        PMID: 14575825     DOI: 10.1016/s0360-3016(03)00665-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  30 in total

1.  Current role of spacers for prostate cancer radiotherapy.

Authors:  Michael Pinkawa
Journal:  World J Clin Oncol       Date:  2015-12-10

2.  Effectiveness of sacral nerve stimulation in fecal incontinence after multimodal oncologic treatment for pelvic malignancies: a multicenter study with 2-year follow-up.

Authors:  M Schiano di Visconte; G A Santoro; N Cracco; G Sarzo; G Bellio; M Brunner; Z Cui; K E Matzel
Journal:  Tech Coloproctol       Date:  2018-01-08       Impact factor: 3.781

3.  On the impact of functional imaging accuracy on selective boosting IMRT.

Authors:  Y Kim; W A Tomé
Journal:  Phys Med       Date:  2008-01-18       Impact factor: 2.685

Review 4.  Current status of intensity-modulated radiation therapy (IMRT).

Authors:  Kazuo Hatano; Hitoshi Araki; Mitsuhiro Sakai; Takashi Kodama; Naoki Tohyama; Tohru Kawachi; Masaharu Imazeki; Takayuki Shimizu; Tsutomu Iwase; Minoru Shinozuka; Hideyo Ishigaki
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

5.  Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?

Authors:  Mirko Nitsche; Werner Brannath; Matthias Brückner; Dirk Wagner; Alexander Kaltenborn; Nils Temme; Robert M Hermann
Journal:  Br J Radiol       Date:  2016-12-12       Impact factor: 3.039

6.  Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.

Authors:  Susan L Tucker; Lei Dong; Walter R Bosch; Jeff Michalski; Kathryn Winter; Radhe Mohan; James A Purdy; Deborah Kuban; Andrew K Lee; M Rex Cheung; Howard D Thames; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-02       Impact factor: 7.038

7.  Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study).

Authors:  Krista Dawdy; Katija Bonin; Steve Russell; Agnes Ryzynski; Tamara Harth; Christopher Townsend; Stanley Liu; William Chu; Patrick Cheung; Hans Chung; Gerard Morton; Danny Vesprini; Andrew Loblaw; Xingshan Cao; Ewa Szumacher
Journal:  J Cancer Educ       Date:  2018-06       Impact factor: 2.037

Review 8.  Reducing rectal injury during external beam radiotherapy for prostate cancer.

Authors:  Riccardo Valdagni; Tiziana Rancati
Journal:  Nat Rev Urol       Date:  2013-05-14       Impact factor: 14.432

9.  Modeling plan-related clinical complications using machine learning tools in a multiplan IMRT framework.

Authors:  Hao H Zhang; Warren D D'Souza; Leyuan Shi; Robert R Meyer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-01       Impact factor: 7.038

10.  Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis.

Authors:  Cem Onal; Erkan Topkan; Esma Efe; Melek Yavuz; Serhat Sonmez; Aydin Yavuz
Journal:  Radiat Oncol       Date:  2009-05-11       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.